|
GYRE Gyre Therapeutics Inc 1124105 |
| Balance Sheet |
|
Current Assets
|
$122,072,000.00 |
|
Assets
|
$199,255,000.00 |
|
Current Liabilities
|
$28,663,000.00 |
|
Liabilities
|
$34,336,000.00 |
|
Equity
|
$107,928,000.00 |
|
Shares Out
|
106033763.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-13,548,000.00 |
|
Investing Cash Flow
|
$6,702,000.00 |
| Market Analysis |
Market Cap
|
$744,357,016.26 |
|
Price
|
$7.02 |
|
BVPS
|
1.02 |
|
PB
|
6.88 |
|
EPS
|
-0.12 |
|
PS
|
6.39 |
|
FCF
|
$-13,988,000.00 |
|
| Dividends |
|
Dividend Amount
|
1.43 |
|
Dividend Data Last Updated
|
2026-09-01 09:32:38 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:29 |
|
| Apr |
May |
Jun |
| 2026-03-12 |
-0.02 |
|
|
2026-05-07 |
-0.10 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-11 |
0.00 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-07 |
0.04 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view GYRE documents filed with the SEC.
GYRE Filings
Clear
